Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV000581529 | SCV000690427 | likely benign | Hereditary cancer-predisposing syndrome | 2016-07-12 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001613388 | SCV001833482 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002061860 | SCV002368712 | likely benign | Hereditary nonpolyposis colorectal neoplasms | 2025-01-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000581529 | SCV004849131 | uncertain significance | Hereditary cancer-predisposing syndrome | 2015-06-11 | criteria provided, single submitter | clinical testing | The c.4001+15A>G intronic alteration consists of a A to G substitution 5 nucleotides after coding exon 9 in the MSH6 gene. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Clinical Genetics, |
RCV001613388 | SCV002034375 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV001613388 | SCV002035570 | likely benign | not provided | no assertion criteria provided | clinical testing |